Is antiperspirant considered an OTC drug in the USA, and what does that mean for private label?

Yes. In the US, antiperspirant is generally regulated as an FDA OTC drug (because it affects sweating), which means your private label must follow OTC rules for active ingredients, Drug Facts labeling, and compliant claims—not just cosmetic rules.

US buyer view Launch planning Updated: January 27, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • In the US, antiperspirants are typically FDA-regulated OTC drugs (commonly aluminum salt actives).
  • For private label, that impacts: allowed actives/strengths and claims, required Drug Facts panel + directions/warnings, and stronger expectations around GMP, traceability, and supporting data.
  • We can support documentation and testing coordination, but you (as the US brand) remain responsible for meeting FDA requirements.
  • From our side at LAEYO Labs, we can start with custom formula development and lab sampling (stick/roll-on/spray depends on your positioning).
  • MOQ is product/packaging dependent; for a market test, many brands start around 3,000-5,000 units per SKU, then scale.
  • We can help with concept positioning, product architecture, insert/price list drafts, and full VI + packaging sourcing.
  • Typical timelines: bulk production is usually 10-20 working days after final sample/pack approval; packaging components often take 10-30 working days (e.g., glass 15 days, acrylic 30 days, tubes 15 days).
  • For a full “brand one-stop” launch, plan about 45-60 days.
  • We can also arrange third-party testing and track reports, plus provide logistics/shipping support.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).